Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Negative pressure wound therapy industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Wound type trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Negative Pressure Wound Therapy Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing incidences of chronic diseases
3.3.1.2. Growing geriatric population base worldwide
3.3.1.3. Technological advancement in negative pressure wound therapy devices in North America
3.3.1.4. Rising usage of NPWT in maxillofacial applications
3.3.1.5. Increasing number of surgical procedures globally
3.3.1.6. Positive regulatory scenario for negative wound pressure therapy devices
3.3.2. Industry pitfalls & challenges
3.3.2.1. Prohibitive cost of NPWT
3.3.2.2. Complications associated with the usage of negative pressure therapy
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By wound type
3.4.3. By end-use
3.5. Porter’s analysis
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Negative Pressure Wound Therapy Market, By Type
4.1. Key segment trends
4.2. Single-use
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Conventional
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Negative Pressure Wound Therapy Market, By Wound Type
5.1. Key segment trends
5.2. Diabetic wounds
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. Skin burns
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. Pressure wounds
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Surgical wounds
5.5.1. Market size, by region, 2014-2025 (USD Million)
5.6. Venous leg ulcers
5.6.1. Market size, by region, 2014-2025 (USD Million)
5.7. Others
5.7.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Negative Pressure Wound Therapy Market, By End-use
6.1. Key segment trends
6.2. Hospitals
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Homecare settings
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Others
6.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Negative Pressure Wound Therapy Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market size, by country, 2014-2025 (USD Million)
7.2.2. Market size, by type, 2014-2025 (USD Million)
7.2.3. Market size, by wound type, 2014-2025 (USD Million)
7.2.4. Market size, by end-use, 2014-2025 (USD Million)
7.2.5. U.S.
7.2.5.1. Market size, by type, 2014-2025 (USD Million)
7.2.5.2. Market size, by wound type, 2014-2025 (USD Million)
7.2.5.3. Market size, by end-use, 2014-2025 (USD Million)
7.2.6. Canada
7.2.6.1. Market size, by type, 2014-2025 (USD Million)
7.2.6.2. Market size, by wound type, 2014-2025 (USD Million)
7.2.6.3. Market size, by end-use, 2014-2025 (USD Million)
7.3. Europe
7.3.1. Market size, by country, 2014-2025 (USD Million)
7.3.2. Market size, by type, 2014-2025 (USD Million)
7.3.3. Market size, by wound type, 2014-2025 (USD Million)
7.3.4. Market size, by end-use, 2014-2025 (USD Million)
7.3.5. Germany
7.3.5.1. Market size, by type, 2014-2025 (USD Million)
7.3.5.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.5.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.6. UK
7.3.6.1. Market size, by type, 2014-2025 (USD Million)
7.3.6.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.6.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.7. France
7.3.7.1. Market size, by type, 2014-2025 (USD Million)
7.3.7.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.7.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.8. Italy
7.3.8.1. Market size, by type, 2014-2025 (USD Million)
7.3.8.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.8.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.9. Spain
7.3.9.1. Market size, by type, 2014-2025 (USD Million)
7.3.9.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.9.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.10. Netherlands
7.3.10.1. Market size, by type, 2014-2025 (USD Million)
7.3.10.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.10.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.11. Belgium
7.3.11.1. Market size, by type, 2014-2025 (USD Million)
7.3.11.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.11.3. Market size, by end-use, 2014-2025 (USD Million)
7.3.12. Austria
7.3.12.1. Market size, by type, 2014-2025 (USD Million)
7.3.12.2. Market size, by wound type, 2014-2025 (USD Million)
7.3.12.3. Market size, by end-use, 2014-2025 (USD Million)
7.4. Asia Pacific
7.4.1. Market size, by country, 2014-2025 (USD Million)
7.4.2. Market size, by type, 2014-2025 (USD Million)
7.4.3. Market size, by wound type, 2014-2025 (USD Million)
7.4.4. Market size, by end-use, 2014-2025 (USD Million)
7.4.5. China
7.4.5.1. Market size, by type, 2014-2025 (USD Million)
7.4.5.2. Market size, by wound type, 2014-2025 (USD Million)
7.4.5.3. Market size, by end-use, 2014-2025 (USD Million)
7.4.6. India
7.4.6.1. Market size, by type, 2014-2025 (USD Million)
7.4.6.2. Market size, by wound type, 2014-2025 (USD Million)
7.4.6.3. Market size, by end-use, 2014-2025 (USD Million)
7.4.7. Japan
7.4.7.1. Market size, by type, 2014-2025 (USD Million)
7.4.7.2. Market size, by wound type, 2014-2025 (USD Million)
7.4.7.3. Market size, by end-use, 2014-2025 (USD Million)
7.4.8. Australia
7.4.8.1. Market size, by type, 2014-2025 (USD Million)
7.4.8.2. Market size, by wound type, 2014-2025 (USD Million)
7.4.8.3. Market size, by end-use, 2014-2025 (USD Million)
7.5. Latin America
7.5.1. Market size, by country, 2014-2025 (USD Million)
7.5.2. Market size, by type, 2014-2025 (USD Million)
7.5.3. Market size, by wound type, 2014-2025 (USD Million)
7.5.4. Market size, by end-use, 2014-2025 (USD Million)
7.5.5. Brazil
7.5.5.1. Market size, by type, 2014-2025 (USD Million)
7.5.5.2. Market size, by wound type, 2014-2025 (USD Million)
7.5.5.3. Market size, by end-use, 2014-2025 (USD Million)
7.5.6. Mexico
7.5.6.1. Market size, by type, 2014-2025 (USD Million)
7.5.6.2. Market size, by wound type, 2014-2025 (USD Million)
7.5.6.3. Market size, by end-use, 2014-2025 (USD Million)
7.5.7. Argentina
7.5.7.1. Market size, by type, 2014-2025 (USD Million)
7.5.7.2. Market size, by wound type, 2014-2025 (USD Million)
7.5.7.3. Market size, by end-use, 2014-2025 (USD Million)
7.6. MEA
7.6.1. Market size, by country, 2014-2025 (USD Million)
7.6.2. Market size, by type, 2014-2025 (USD Million)
7.6.3. Market size, by wound type, 2014-2025 (USD Million)
7.6.4. Market size, by end-use, 2014-2025 (USD Million)
7.6.5. South Africa
7.6.5.1. Market size, by type, 2014-2025 (USD Million)
7.6.5.2. Market size, by wound type, 2014-2025 (USD Million)
7.6.5.3. Market size, by end-use, 2014-2025 (USD Million)
7.6.6. Saudi Arabia
7.6.6.1. Market size, by type, 2014-2025 (USD Million)
7.6.6.2. Market size, by wound type, 2014-2025 (USD Million)
7.6.6.3. Market size, by end-use, 2014-2025 (USD Million)
7.6.7. UAE
7.6.7.1. Market size, by type, 2014-2025 (USD Million)
7.6.7.2. Market size, by wound type, 2014-2025 (USD Million)
7.6.7.3. Market size, by end-use, 2014-2025 (USD Million)
7.6.8. Kuwait
7.6.8.1. Market size, by type, 2014-2025 (USD Million)
7.6.8.2. Market size, by wound type, 2014-2025 (USD Million)
7.6.8.3. Market size, by end-use, 2014-2025 (USD Million)
7.6.9. Qatar
7.6.9.1. Market size, by type, 2014-2025 (USD Million)
7.6.9.2. Market size, by wound type, 2014-2025 (USD Million)
7.6.9.3. Market size, by end-use, 2014-2025 (USD Million)
Chapter 8. Company Profiles
8.1. Acelity
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Atmos
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. ConvaTec
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Cork Medical
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. DeRoyal
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Genadyne Biotechnologies Inc
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. Medela Inc
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Medtronic
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Smith & Nephew Inc
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. TRIAGE MEDITECH PVT. LTD.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
